home.aspx
 
. https://biotechnology.report/Resources/Whitepapers/77a97834-99f2-4d1f-b799-38bca105b537_{320390ed-5266-44c7-8e16-1651dc691991}_whp-thermo-1017_final_version.pdf
whitepaper
SHARESHARESHARE
MASS SPECTROMETRIC ANALYSIS OF INTACT COMPLEX BIOTHERAPEUTICS
The benefit of therapeutic antibodies is their ability to be inherently more selective than traditional small-molecule pharmaceuticals through specific binding activities, lower toxicity, and higher efficacy. And the proof of their benefits is in the numbers: The U.S. Food & Drug Administration approved 68 such therapeutics by the beginning of 2017, and more than 50 are being evaluated in late-stage clinical studies for a range of indications. DOWNLOAD